Quantcast

Latest Hae Stories

2014-08-22 08:24:50

BRAINTREE, Mass., Aug. 22, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on September 8(th), 2014 at 8:45am Eastern time. The public may access Mr. Concannon's presentation live via webcast at: http://cc.talkpoint.com/morg007/090814a_ac/?entity=95_Q4T6LED About HaemoneticsHaemonetics (NYSE: HAE) is a global healthcare company dedicated to...

2014-07-23 12:31:19

BRAINTREE, Mass., July 23, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Charles J. Dockendorff was elected to the Board of Directors at the Company's Annual Meeting of Stockholders today. Mr. Dockendorff, age 59, is Executive Vice President and Chief Financial Officer with Covidien PLC, a position he has held since 1995. He is responsible for Covidien's financial management activities including corporate accounting, tax, treasury, financial planning,...

2014-06-30 08:30:22

BRAINTREE, Mass., June 30, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will announce its earnings for the first quarter of its fiscal year 2015 on Wednesday, July 30, 2014 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern on July 30, 2014. Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=5163769 Webcast replay will be available...

2014-05-28 08:31:24

BRAINTREE, Mass., May 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP, Business Development, will present at the William Blair & Company Growth Stock Conference in Chicago on June 11(th), 2014 at 2:20pm Eastern time. The public may access Mr. Lindop's presentation live via webcast at: http://wsw.com/webcast/blair48/hae About HaemoneticsHaemonetics (NYSE: HAE) is a global healthcare company dedicated to providing...

2014-05-27 08:28:46

BRAINTREE, Mass., May 27, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at The Goldman Sachs 35(th) Annual Global Healthcare Conference in California on June 12(th), 2014 at 12:20pm Eastern time. The public may access Mr. Concannon's presentation live via webcast at: http://cc.talkpoint.com/gold006/061014a_an/?entity=44_HWB0858 About HaemoneticsHaemonetics (NYSE: HAE) is a global healthcare...

2014-05-23 16:24:00

BRAINTREE, Mass., May 23, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP-Business Development, will present at The Jefferies 2014 Global Healthcare Conference in New York on June 4(th), 2014 at 2:30pm Eastern time. The public may access Mr. Lindop's presentation live via webcast at: http://wsw.com/webcast/jeff82/hae About HaemoneticsHaemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative...

2014-05-20 08:31:54

CARLSBAD, Calif., May 20, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it initiated a Phase 1 clinical study of ISIS-PKK(Rx). ISIS-PKK(Rx) is an antisense drug in development to treat patients with hereditary angioedemia (HAE). HAE is a rare genetic disease that is characterized by rapid and painful attacks of inflammation in the hands, feet, limbs, face, abdomen, larynx and trachea. HAE affects approximately 20,000 patients in the United...

2014-05-14 08:31:29

Third annual awareness day shines a light on rare, potentially life-threatening condition KING OF PRUSSIA, Pa., May 14, 2014 /PRNewswire/ -- As a Diamond Sponsor of HAE Day on May 16, 2014, CSL Behring is proud to continue its partnership with HAEi, the International Patient Organization for C1 Inhibitor Deficiencies, and patient organizations throughout the world. HAE, or, hereditary angioedema, is a rare, potentially fatal swelling disorder caused by a deficiency of C1-INH, a type of...

2014-04-28 08:30:40

BRAINTREE, Mass., April 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that its Board of Directors has approved the repurchase of up to $100 million of shares, consistent with its loan covenants. In approving the repurchase, the Board acknowledged the company's strong cash flow and $192 million cash balance. Haemonetics President and CEO stated: "Our Board of Directors expressed confidence in the Company's strategic plan and cash generating ability. We...

2014-04-01 16:25:42

BRAINTREE, Mass., April 1, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2014 and will provide guidance for fiscal year 2015( )on April 28, 2014 in a pre-market press release. The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on April 28, 2014. Webcast Link:...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related